本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aurinia Pharmaceuticals Inc

7.59
+0.10001.34%
盘后7.57-0.0200-0.26%16:49 EDT
成交量:100.85万
成交额:759.40万
市值:10.25亿
市盈率:28.53
高:7.61
开:7.51
低:7.45
收:7.49
数据加载中...
2020/03/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

年度报告

Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2020/03/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/18

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/10

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/06

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]